Biotech Values

[DewDiligence]

[MYL] The plot thickens:

http://www.thestreet.com/_yahoo/stocks/biotech/10179166.html?cm_ven=YAHOO&cm_cat=FREE&cm_ite....

>>
Mylan Labs Says Icahn Eyes Stake

By Robert Steyer
TheStreet.com
8/19/2004 9:43 AM EDT

Mylan Laboratories (MYL:NYSE) Thursday said that billionaire investor Carl Icahn has been given the OK by the Federal Trade Commission to purchase some of the company's stock.

Pittsburgh-based Mylan, which makes generic and brand-name drugs, said the FTC granted early termination of the Hart-Scott-Rodino waiting period relating to an Icahn application to buy between $100 million and $500 million worth of Mylan's stock.
Based on Wednesday's closing price of $15.58, Icahn would be able to purchase 2.4% to 11.9% of Mylan's shares without making a further filing with regulators.

In pre-market trading, Mylan's shares jumped $1.12, or 7.2%, to $16.70.

Mylan said it hadn't talked to Icahn, adding that it doesn't know how much he will buy. The company declined further comment.

Mylan is seeking to acquire King Pharmaceuticals (KG:NYSE - commentary - research)in a $4 billion stock swap deal announced in late July.

Icahn recently sold a part of his large stake in ImClone Systems.
<<